Intracranial Tumors Clinical Trial
Official title:
Assessment of Early Detection Based on Liquid Biopsy in Intracranial Tumors: a Prospective Observational Study
ASCEND-BRAIN is a prospective, observational study aimed at early-detection of intracranial tumors by combined assays of cfDNA methylation and other biomarkers. The study will enroll approximately 358 participants including intracranial malignant tumors, patients with benign disorders of central nervous system and healthy participants.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02431572 -
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
|
N/A |